Document is current
Any future updates will be listed below
-
Authors
Hase, Tetsunari https://orcid.org/0000-0002-9653-8424
Miyazaki, Masayuki
Ichikawa, Kazuya
Yogo, Naoyuki
Ozawa, Naoya
Hatta, Takahiro
Ando, Masahiko
Sato, Mitsuo
Kondo, Masashi
Yamada, Kiyofumi
Hasegawa, Yoshinori
-
Funding
Funding for this research was provided by:
Ministry of Education, Culture, Sports, Science and Technology of Japan (17K09651)
- License Information
-
More Information
Article History
Received: 20 April 2020
Accepted: 15 July 2020
First Online: 1 August 2020
Compilance with ethical standards
:
: T. Hase received honoraria from Chugai Pharmaceutical Co., Ono Pharmaceutical Co., AstraZeneca, Bristol-Myers Squibb K.K., Pfizer Inc., Boehringer Ingelheim, and Eli Lilly Japan K.K. and research funding from Boehringer Ingelheim. Y. Hasegawa received grants from Boehringer Ingelheim, AstraZeneca, Eli Lilly Japan K.K., Ono Pharmaceutical Co., Bristol-Myers Squibb K.K., Taiho Pharmaceutical Co., Novartis Pharma K. K., and Chugai-Pharmaceutical Co. and honoraria from Boehringer Ingelheim, MSD K.K., AstraZeneca, Pfizer Inc., and Chugai-Pharmaceutical Co. M. Sato received a research funding from Pfizer Inc. All grants were paid to Nagoya University.
